Five things for pharma marketers to know: Friday, June 24, 2016

Five things for pharma marketers to know: Friday, June 24, 2016

Brexit votes creates EU regulatory uncertainty; Obama plans to veto health saving accounts bill; broad Entresto adoption could prevent more than 28,000 deaths

Five things for pharma marketers to know: Thursday, June 23, 2016

Five things for pharma marketers to know: Thursday, June 23, 2016

Medicare cost-cutting panel will not be activated this year; more Americans are abusing opioids; BIO blasts ICER

Razorfish Health names new managing director

Razorfish Health names new managing director

David Paragamian, previously of Huntsworth Health, is the new managing director of Razorfish Health.

Five things for pharma marketers to know: Wednesday, June 22, 2016

Five things for pharma marketers to know: Wednesday, June 22, 2016

Women use apps to get prescriptions for birth control; BMS names Gordon to chief commercial role; Takeda's Actos may halt progression of liver disease;

Ruder Finn hires Sally Barton to lead U.S. healthcare, creates new role for Susan Goldstein

Ruder Finn hires Sally Barton to lead U.S. healthcare, creates new role for Susan Goldstein

The agency has hired Sally Barton as head of the U.S. healthcare practice/

Five things for pharma marketers to know: Tuesday, June 21, 2016

Five things for pharma marketers to know: Tuesday, June 21, 2016

Cancer docs push HPV vaccine; GSK says experimental lung combo trumps Symbicort; Google rolls out new symptom search feature

Zika campaign highlights millennial interest in work with a purpose

Zika campaign highlights millennial interest in work with a purpose

A group of Havas agencies developed a song and a ritual for a Reckitt Benckiser campaign encouraging people to use mosquito repellant.

No free lunch for docs: Sponsored meals linked to more prescriptions

No free lunch for docs: Sponsored meals linked to more prescriptions

A new analysis suggests that $20 industry-sponsored meals may sway docs' prescribing habits.

Five things for pharma marketers to know: Monday, June 20, 2016

Five things for pharma marketers to know: Monday, June 20, 2016

Novartis plans to launch five biosimilars; Making A Murderer directors will create project based on J&J investigation; Biogen plans to close or sell manufacturing plant

There's no such thing as gay blood, says campaign from FCB Health

There's no such thing as gay blood, says campaign from FCB Health

After the Orlando shooting, gay men were turned away from blood drives. A campaign explaining why had to reexamine its strategy

What pharma brands can learn from Lions Health

What pharma brands can learn from Lions Health

Drugmakers test out virtual reality, partner with companies like Spotify, and go for the cinematic at Cannes Lions.

McCann Health named Lions Health Network of the Year

McCann Health named Lions Health Network of the Year

McCann Health was named Network of the Year at the Cannes Lions Health festival of creativity in Cannes.

Galderma exec: Skip the market research (sometimes)

Galderma exec: Skip the market research (sometimes)

TBWA/WorldHealth worked with Galderma to get rid of the traditional process in which an agency and its client interact in effort to improve the work.

Philips takes the pharma Grand Prix at Cannes

Philips takes the pharma Grand Prix at Cannes

Ogilvy & Mather London developed the campaign, called Breathless Choir and set to Sting's "Every Breath You Take."

Lions Health 2016: health and wellness winners

Lions Health 2016: health and wellness winners

The Lions Health 2016 health and wellness category winners.

Lions Health 2016: pharma winners

Lions Health 2016: pharma winners

The Lions Health 2016 pharma category winners.

Lions Health 2016: pharma shortlist

Lions Health 2016: pharma shortlist

The shortlist for Lions Health 2016's pharma category.

Lions Health 2016: health and wellness shortlist

Lions Health 2016: health and wellness shortlist

The shortlist for Lions Health 2016's health and wellness category.

Five things for pharma marketers to know: Friday, June 17, 2016

Five things for pharma marketers to know: Friday, June 17, 2016

Hillary Clinton receives more donations from pharma than republicans; biotech reps have highest salaries; NICE recommends Yervoy-Opdivo combo

Dip seen in shortlisted U.S. pharma work at Lions Health

Dip seen in shortlisted U.S. pharma work at Lions Health

The jurors advanced 103 entries in the pharma category of Lions Health. U.S. agencies accounted for 16 of them.

New first-line lung data is positive for Merck's Keytruda, but competitor looms large

New first-line lung data is positive for Merck's Keytruda, but competitor looms large

A trial studying Keytruda met its endpoint in first-line lung cancer patients.

FleishmanHillard veteran Betsy Neville launches healthcare shop Hippos

FleishmanHillard veteran Betsy Neville launches healthcare shop Hippos

Betsy Neville, former senior partner and leader of the reputation management practice for the Americas at FleishmanHillard, has launched her own healthcare communications agency.

Pharma's complexity calls for a closer look at creativity

Pharma's complexity calls for a closer look at creativity

The discontinuation of the Take It From a Fish campaign can serve as an example of the common ups-and-downs of pharma marketing.

Five things for pharma marketers to know: Thursday, June 16, 2016

Five things for pharma marketers to know: Thursday, June 16, 2016

A government watchdog criticizes the FDA; the FDA strengthens kidney warnings for Invokana and Farxiga; people with diabetes are living longer

Five things for pharma marketers to know: Wednesday, June 15, 2016

Five things for pharma marketers to know: Wednesday, June 15, 2016

Hospitals struggle with high drug costs; the FDA approves new weight loss device; the ADA asks docs not to tweet, but they did anyway

Cannes Lions sees record 43,000 award submissions

Cannes Lions sees record 43,000 award submissions

Health and wellness entries are up 42% to 2,024 in 2016, compared to 1,430 in 2015, while pharma entries increased 35% to 583 this year.

Reputation Institute: Talc lawsuits not hurting J&J's image with millennials

Reputation Institute: Talc lawsuits not hurting J&J's image with millennials

According to research conducted in the first quarter, the healthcare products company has a sterling image with millennials despite a series of legal judgments against the company.

Remedy Health Media launches new series: a peek into patients' lives

Remedy Health Media launches new series: a peek into patients' lives

Remedy Health, taking a cue from Humans of New York, offers snapshots of patients' stories.

How a startup is educating kids with diabetes with a teddy bear

How a startup is educating kids with diabetes with a teddy bear

Sproutel CEO Aaron Horowitz talks about how Jerry the Bear came to life and why endocrinologists are stocking the bear in their offices.

Five things for pharma marketers to know: Tuesday, June 14, 2016

Five things for pharma marketers to know: Tuesday, June 14, 2016

Physicians debate DTC tax write-off; Novo Nordisk's Victoza shows 13% benefit in reducing cardiovascular risks; Shire to acquire Pfizer bowel drug

How Kathy Delaney does Cannes

How Kathy Delaney does Cannes

On creativity: "Creativity can emerge from anywhere and anyone at any time. Medical breakthroughs aren't just discovered by scientists and researchers anymore."

How Chris Duffey does Cannes

How Chris Duffey does Cannes

Everything from the brand promise to the campaign solution to the case-study video — it all has to be based in authenticity, he says.

How Jeremy Perrott does Cannes

How Jeremy Perrott does Cannes

MM&M asks: What was the ROI for putting a McCann Health smiley face on the steps of the Palais?

Five things for pharma marketers to know: Monday, June 13, 2016

Five things for pharma marketers to know: Monday, June 13, 2016

A new Sanofi combination diabetes drug meets clinical trial targets; IBM partners with the American Diabetes Association; Dr. Reddy's to buy eight Teva drugs

What millennial women expect in the workplace

What millennial women expect in the workplace

Three executives shared some of the challenges women face in the workplace and how they want to shape the next generation of female leaders.

Aetna hires new chief comms officer

Aetna hires new chief comms officer

Her hire comes as the insurance giant is merging with Humana in a $37 billion deal.

Panel: Why data is the first step in telling a human story

Panel: Why data is the first step in telling a human story

The ability to pair data with a story or a human emotion is often easier for women,

Five things for pharma marketers to know: Friday, June 10, 2016

Five things for pharma marketers to know: Friday, June 10, 2016

FDA leader says drugmakers should develop more novel drugs; Merck to acquire Afferent for $1.25 billion; Colombia demands lower prices for Gleevec

Women in senior industry roles improve connections with patients, execs say

Women in senior industry roles improve connections with patients, execs say

Most healthcare consumers are women, which makes it easier for female healthcare marketers to connect and understand their needs.

HealthiNation trades content for email addresses in holiday campaign

HealthiNation trades content for email addresses in holiday campaign

The health video startup ran a campaign in which it exchanged holiday cookbooks for email addresses.

Five things for pharma marketers to know: Thursday, June 9, 2016

Five things for pharma marketers to know: Thursday, June 9, 2016

Industry lobbying group plans counteroffensive; the FDA rejected a record high amount generic drug applications; adcomm recommends Pfizer painkiller

Q&A: Omnicom Health Group's Josh Prince on provoking conversation in healthcare

Q&A: Omnicom Health Group's Josh Prince on provoking conversation in healthcare

He talks about the three qualities that make for a great campaign and why conservatism will not help drugmakers address reputational issues.

Boehringer Ingelheim launches gamified support program

Boehringer Ingelheim launches gamified support program

BI launched a new gamified patient support program aimed at improving adherence to its COPD medication.

Five things for pharma marketers to know: Wednesday, June 8, 2016

Five things for pharma marketers to know: Wednesday, June 8, 2016

Bing can identify people with cancer symptoms; an experimental rheumatoid arthritis meets trial goals; the FDA updates compassionate use rules

Valeant CEO blames salesforce turnover for disappointing Xifaxan sales

Valeant CEO blames salesforce turnover for disappointing Xifaxan sales

Turnover in the company's salesforce for its flagship brand have led to disappointing sales, according to Valeant brass.

Q&A: Publicis' Alexandra von Plato on Cannes

Q&A: Publicis' Alexandra von Plato on Cannes

She discusses why it's wrong to compare the pharmaceutical industry to Skittles and why she expects to see more risk-taking in this year's creative work.

Five things for pharma marketers to know: Tuesday, June 7, 2016

Five things for pharma marketers to know: Tuesday, June 7, 2016

Gilead CEO talks drug pricing; multiple-sclerosis drugmakers study the overall cost of care; Biden launches national cancer database

Concentric promotes three as managing partner departs

Concentric promotes three as managing partner departs

The healthcare agency promoted three executives to SVP and said a search for a new president is underway.

The CIO, reimagined for pharma

The CIO, reimagined for pharma

Despite the increasing importance of the CIO post, top technology professionals still find it hard to break into the uppermost ranks at life-sciences companies.

Bristol-Myers Squibb's Yervoy, Opdivo combo data confers edge in lung cancer

Bristol-Myers Squibb's Yervoy, Opdivo combo data confers edge in lung cancer

Investors said a combination of Opdivo and Yervoy is the top-performing regimen in a niche of non-small cell lung-cancer patients.

Five things for pharma marketers to know: Monday, June 6, 2016

Five things for pharma marketers to know: Monday, June 6, 2016

Researchers question cost of multiple-myeloma combo; drugmakers say CAR-T therapies will soon be approved; the FDA approves Allergan's hypertension drug

Pharma companies turn to wearables to improve R&D

Pharma companies turn to wearables to improve R&D

Drugmakers and tech companies are developing wearables and using popular fitness trackers like the Fitbit in clinical trials to gain insights about Parkinson's Disease.

Pfizer ad celebrates the sweat and science behind the little blue pills

Pfizer ad celebrates the sweat and science behind the little blue pills

As Viagra goes generic, the pharma giant launches a feel-good corporate campaign.

Five things for pharma marketers to know: Friday, June 3, 2016

Five things for pharma marketers to know: Friday, June 3, 2016

Generic drugmakers consider pricing strategies; Mary Meeker predicts images and search will be half of online searches; drugmakers use comics to market

ASCO 2016 Preview: Expect data on CDK inhibitors, CAR-T therapies, and pricing

ASCO 2016 Preview: Expect data on CDK inhibitors, CAR-T therapies, and pricing

Competition among new breast cancer drugs, an immunotherapy contender, and pricing discussions headline one of the biggest cancer conferences of the year.

Five things for pharma marketers to know: Thursday, June 2, 2016

Five things for pharma marketers to know: Thursday, June 2, 2016

Pfizer releases new campaign; progressive research group calls out PCORI; U.S. drugmakers hire auditors they have ties with

Leadership Exchange: Engaging the Millennial Doctor

Leadership Exchange: Engaging the Millennial Doctor

In partnership with inVentiv Health, MM&M found a millennial doctor to ask about her frustrations with the existing pharma marketing model to her willingness to text patients.

Klick opens NY office with slew of agency 'rock stars'

Klick opens NY office with slew of agency 'rock stars'

New creative, account planning, and payer access talent lays groundwork for agency's first formal ex-Canada office.

Pharma is reluctant to adopt digital in R&D: survey

Pharma is reluctant to adopt digital in R&D: survey

Only 55% of the surveyed pharmaceutical executives said they are adopting digital as a key strategy in R&D.

Five things for pharma marketers to know: Wednesday, June 1, 2016

Five things for pharma marketers to know: Wednesday, June 1, 2016

WHO finds poor countries are paying too much for HCV drugs; Gilead faces a lawsuit over an HIV drug; BioMarin to stop developing Duchenne treatment

Sudler NY reorganizes, promotes 6 to EVP

Sudler NY reorganizes, promotes 6 to EVP

The agency underwent a reorganization just months after its parent company, Sudler & Hennessey, did the same.

Five things for pharma marketers to know: Tuesday, May 31, 2016

Five things for pharma marketers to know: Tuesday, May 31, 2016

Lawmaker calls for investigation of Purdue; Jazz to acquire Celator; Intercept's liver drug is approved

Telehealth: Improving the customer experience but still an unknown for pharma

Telehealth: Improving the customer experience but still an unknown for pharma

Although telehealth is still in its early stages, it's building momentum — with good reason.

Five things for pharma marketers to know: Friday, May 27, 2016

Five things for pharma marketers to know: Friday, May 27, 2016

Baby powder lawsuit impacts J&J's reputation; new bacterial infection raises concern about treatment options; Valeant reportedly rejected offer from Takeda

AstraZeneca pulls Take it From a Fish campaign

AstraZeneca pulls Take it From a Fish campaign

The unbranded campaign won the top prize at the 2015 Lions Health festival in Cannes.

Five things for pharma marketers to know: Thursday, May 26, 2016

Five things for pharma marketers to know: Thursday, May 26, 2016

BIO report finds success rate in Phase-I is 10%; Dunsire departs Forum after failed trials; the FDA issues two warning letters

Infographic: Merck's Keytruda versus Bristol-Myers Squibb's Opdivo

Infographic: Merck's Keytruda versus Bristol-Myers Squibb's Opdivo

Here, see side-by-side comparisons of the drugs spending on advertising, approval dates, and 2015 sales figures.

The commercial carousel continues to spin: Gilead's head of commercial departs

The commercial carousel continues to spin: Gilead's head of commercial departs

Gilead announced that its head of commercial operations left the company.

Conflicting polls highlight uncertainty about the public's opinion of pharma

Conflicting polls highlight uncertainty about the public's opinion of pharma

Two recent polls paint a complicated picture of the public's opinion of the pharma industry.

Five things for pharma marketers to know: Wednesday, May 25, 2016

Five things for pharma marketers to know: Wednesday, May 25, 2016

Antidepressants are often used to treat conditions other than depression; the FDA delays decision on Duchenne drug; Lilly and Pfizer develop new painkiller

What do physicians think about biosimilars?

What do physicians think about biosimilars?

A SERMO poll asked physicians: Do you feel biosimilars will prove safe and effective enough for you to prescribe them when more become available?"

Merck educates doctors about biosimilars, long before it will sell one in the U.S.

Merck educates doctors about biosimilars, long before it will sell one in the U.S.

Drugmakers like Merck are making a big education push as they lay the groundwork for future biosimilars.

Five things for pharma marketers to know: Tuesday, May 24, 2016

Five things for pharma marketers to know: Tuesday, May 24, 2016

The FDA accepts Samsung's biosimilar for review; Sanofi retools executive committee; Entresto may get a boost from updated care guidelines

Practice Fusion founder launches heart-monitoring wearable

Practice Fusion founder launches heart-monitoring wearable

The new company, iBeat, plans to market a wearable device that can detect the symptoms of cardiac arrest and heart attacks.

Pfizer's smoking-cessation app came from internal competition

Pfizer's smoking-cessation app came from internal competition

Pfizer brand teams competed in a shark-tank style challenge, with the winning teams receiving funding for their ideas.

J&J taps Sneed as communications chief

J&J taps Sneed as communications chief

Johnson & Johnson has appointed Michael Sneed, its worldwide VP of global corporate affairs, to the additional role of chief communications officer.

4 trends with the potential to change behavior in the patient journey

4 trends with the potential to change behavior in the patient journey

It's a common refrain in healthcare and among patients, providers, and payers: Despite massive investment, no one has figured out how to change human behavior.

Five things for pharma marketers to know: Monday, May 23, 2016

Five things for pharma marketers to know: Monday, May 23, 2016

E.U. lifts warning on Pfizer's Chantix; Obama's Medicare Part B proposal panned by lawmakers; France to propose stricter rules for clinical trials

Top 25 infectious disease products in 2015

Top 25 infectious disease products in 2015

To no surprise, Gilead Sciences' Harvoni and Sovaldi were the top-selling infectious disease products in 2015.

Drugmakers renew interest in antibiotic development

Drugmakers renew interest in antibiotic development

The goal is to develop medications that move beyond the high-toxicity and low-efficacy profiles of older drugs.

Competition may threaten Gilead as market leader

Competition may threaten Gilead as market leader

Even as Gilead prepares to launch a third hepatitis-C product, drugs offering better antimicrobial resistance are angling for their own moments in the spotlight.

W2O sells stake to private-equity firm

W2O sells stake to private-equity firm

The agency network said the private equity firm won't be involved in its day-to-day operations, but it will help its growth strategy.

Five things for pharma marketers to know: Friday, May 20, 2016

Five things for pharma marketers to know: Friday, May 20, 2016

Keytruda's survival benefit is reinforced by new study; drugmakers reference patient-assistance programs in debate over drug prices; China cuts drug prices

Blue Cross Blue Shield RI on introducing email segmentation

Blue Cross Blue Shield RI on introducing email segmentation

Health insurance provider Blue Cross Blue Shield Rhode Island drove engagement, leads, and conversion through its segmented campaigns.

Five things for pharma marketers to know: Thursday, May 19, 2016

Five things for pharma marketers to know: Thursday, May 19, 2016

Novartis plans new trials for Entresto; U.S. spending on mental health topped $201 billion in 2013; the FDA approves Roche's immunotherapy drug

Industry criticizes FDA's proposed DTC studies

Industry criticizes FDA's proposed DTC studies

Pharma companies took issue with the methodology for the FDA's proposed studies of advertising tactics.

BodenPR helps UnitedHealthcare educate Hispanic seniors about Medicare

BodenPR helps UnitedHealthcare educate Hispanic seniors about Medicare

UnitedHealthcare this month launched a year-long campaign, called Hay Más Adelante.

Five things for pharma marketers to know: Wednesday, May 18, 2016

Five things for pharma marketers to know: Wednesday, May 18, 2016

Opdivo nets new indication; government to view Humira patent; AstraZeneca's asthma drug expected to be filed this year

The Medicines Company appoints former Biogen exec to lead commercial activities

The Medicines Company appoints former Biogen exec to lead commercial activities

Tony Kingsley will oversee the company's daily operations and commercial activities.

Novartis splits pharma division, shakes up management team

Novartis splits pharma division, shakes up management team

Novartis breaks up pharmaceutical division and announces that David Epstein, CEO of Novartis Pharmaceuticals, will leave the company.

Ponemon: Cybercrime is top cause for healthcare data breaches

Ponemon: Cybercrime is top cause for healthcare data breaches

A 69% majority of healthcare organizations said they believe their industry is more vulnerable to data breaches than other business sectors.

Five things for pharma marketers to know: Tuesday, May 17, 2016

Five things for pharma marketers to know: Tuesday, May 17, 2016

Online doctors prescribe drugs without adequate warnings; House lawmakers to discuss Part B proposal; obesity drugs struggle for market share

Valeant offers discounts for high-priced heart drugs

Valeant offers discounts for high-priced heart drugs

The drugmaker said its rebate program will discount Nitropress and Isuprel, following a year of relentless criticism about the prices of the therapies.

Omnicom PR Group acquires healthcare shop Rabin Martin

Omnicom PR Group acquires healthcare shop Rabin Martin

It is the group's first acquisition since it was assembled in February under CEO Karen van Bergen.

Five things for pharma marketers to know: Monday, May 16, 2016

Five things for pharma marketers to know: Monday, May 16, 2016

Pfizer buys Anacor; Harvard Medical School loosens rules for faculty ties to pharma; Vermont poised to pass price transparency bill

U by Kotex opens up a period-themed pop-up shop

U by Kotex opens up a period-themed pop-up shop

"The Period Shop" is the first effort in a multi-year "Period Projects" campaign.

Novartis considers new sales model for experimental cancer therapy

Novartis considers new sales model for experimental cancer therapy

Using a med-tech strategy may help stem concern about CAR T-cell technology's complicated distribution and anticipated high prices, said Novartis exec.

Five things for pharma marketers to know: Friday, May 13, 2016

Five things for pharma marketers to know: Friday, May 13, 2016

HCV market share battle is still underway; Regeneron CEO blasts criticism of Praluent's price; ProPublica database used to find docs to prescribe painkillers

Lobbyists argue DTC ad tax deduction may be a casualty of reform

Lobbyists argue DTC ad tax deduction may be a casualty of reform

Advertising lobbyist said eliminating the DTC ad tax deduction is a real threat to the industry.

OPINION

Email Newsletters